Population pharmacokinetic study in Dravet's syndrome patients treated with stiripentol, valproate and clobazam. Open pharmacokinetic multicenter study.
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Stiripentol (Primary) ; Clobazam; Valproic acid
- Indications Myoclonic epilepsies
- Focus Pharmacogenomic; Pharmacokinetics
- 17 Aug 2017 Results published in the Clinical Pharmacokinetics
- 17 Aug 2017 Status changed from recruiting to completed,as per results published in the Clinical Pharmacokinetics.
- 21 Jun 2011 New trial record